Why are some cells more cancer prone?

August 27, 2013, Carnegie Institution for Science

Cells in the body wear down over time and die. In many organs, like the small intestine, adult stem cells play a vital role in maintaining function by replacing old cells with new ones. Learning about the nature of tissue stem cells can help scientists understand exactly how our organs are built, and why some organs generate cancer frequently, but others only rarely.

New work from Carnegie's Alexis Marianes and Allan Spradling used some of the most experimentally accessible tissue , the adult stem cells in the midsection of the fruit fly gut, with surprising results. Their findings are published by eLife.

Like the small intestine in mammals, the midgut of is where most digestion takes place. Scientists had noticed a few regions in both the midgut and were specialized for certain tasks, such as absorbing iron, but had little understanding of the extent of these regional differences or how they were maintained.

Marianes and Spradling were able to demonstrate that there are 10 different major subregions within the fruit fly midgut. They occur in a specific order and each is responsible for different digestive and nutrient-storage processes, as evidenced by the expression of many specific genes. Most importantly, the in each region are specialized as well, and only support the types of cells found within it. Thus, during development, achieving the right spatial sequence of stem cells is probably critical to causing intestines to be built and maintained in order to function optimally.

The researchers also showed that tumors arise preferentially in specific regions of the midgut, a phenomenon well known in oncology. They showed the tumor-prone regions were specialized for lipid absorption, and stem cell function in them differed in small ways from stem cell function in other regions.

This work will motivate the search for fine-grained specialization in both tissue organization and in stem cells within many mammalian tissues. These subtle differences may explain the surprising results that are sometimes obtained following the removal or transplantation of human tissue. This must be considered carefully in ongoing attempts to utilize stem cells therapeutically.

Finally, it may be possible to learn what makes some stem cells more susceptible to cancer than others, and develop strategies to counteract this tendency.

Explore further: Tracking nanodiamond-tagged stem cells

Related Stories

Tracking nanodiamond-tagged stem cells

August 5, 2013
A method that is used to track the fate of a single stem cell within mouse lung tissue is reported in a study published online this week in Nature Nanotechnology. The method may offer insights into the factors that determine ...

Stem cell discovery furthers research on cell-based therapy and cancer

July 19, 2013
Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.